JP7576375B2 - グリカン調製物及び高アンモニア血症のための使用方法 - Google Patents

グリカン調製物及び高アンモニア血症のための使用方法 Download PDF

Info

Publication number
JP7576375B2
JP7576375B2 JP2020524305A JP2020524305A JP7576375B2 JP 7576375 B2 JP7576375 B2 JP 7576375B2 JP 2020524305 A JP2020524305 A JP 2020524305A JP 2020524305 A JP2020524305 A JP 2020524305A JP 7576375 B2 JP7576375 B2 JP 7576375B2
Authority
JP
Japan
Prior art keywords
glycan
subject
glycan preparation
mol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020524305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021502339A (ja
JP2021502339A5 (https=
Inventor
ギブソン，モリー・クリースアン
ステビンス，ネイサン・ウィルソン
ティエロフ－エケルト，ルース
フォン・マルトツァーン，ジェフリー・エイ
Original Assignee
カレイド・バイオサイエンシズ・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カレイド・バイオサイエンシズ・インコーポレイテッド filed Critical カレイド・バイオサイエンシズ・インコーポレイテッド
Publication of JP2021502339A publication Critical patent/JP2021502339A/ja
Publication of JP2021502339A5 publication Critical patent/JP2021502339A5/ja
Application granted granted Critical
Publication of JP7576375B2 publication Critical patent/JP7576375B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2020524305A 2017-11-03 2018-11-03 グリカン調製物及び高アンモニア血症のための使用方法 Active JP7576375B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762581583P 2017-11-03 2017-11-03
US62/581,583 2017-11-03
US201862673754P 2018-05-18 2018-05-18
US62/673,754 2018-05-18
US201862720924P 2018-08-21 2018-08-21
US62/720,924 2018-08-21
PCT/US2018/059102 WO2019090182A2 (en) 2017-11-03 2018-11-03 Glycan preparations and methods of use for hyperammonemia

Publications (3)

Publication Number Publication Date
JP2021502339A JP2021502339A (ja) 2021-01-28
JP2021502339A5 JP2021502339A5 (https=) 2021-12-16
JP7576375B2 true JP7576375B2 (ja) 2024-10-31

Family

ID=64564984

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524305A Active JP7576375B2 (ja) 2017-11-03 2018-11-03 グリカン調製物及び高アンモニア血症のための使用方法

Country Status (5)

Country Link
US (1) US12090168B2 (https=)
EP (1) EP3703705B1 (https=)
JP (1) JP7576375B2 (https=)
CN (1) CN111315388A (https=)
WO (1) WO2019090182A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1246600B (en) 2015-01-26 2020-04-09 Cadena Bio, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
EP3841127A2 (en) 2018-08-21 2021-06-30 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof for reducing ammonia levels
US11592891B2 (en) * 2019-10-15 2023-02-28 Dell Products L.P. System and method for diagnosing resistive shorts in an information handling system
US11896603B2 (en) * 2020-06-12 2024-02-13 The Regents Of The University Of California Oligosaccharide as therapeutic agent for alcohol associated liver disease
US12508274B2 (en) 2020-07-17 2025-12-30 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods of use
CN112048576A (zh) * 2020-08-03 2020-12-08 徐州工程学院 一种固体酸水解牛蒡制备果糖的方法
AU2021350104A1 (en) * 2020-09-25 2023-06-08 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods of use
CN112326639B (zh) * 2020-11-25 2024-01-05 迈克生物股份有限公司 检测果糖胺的试剂盒和方法
JP2024030913A (ja) * 2022-08-25 2024-03-07 協同乳業株式会社 中高齢の対象の認知的柔軟性を高めるための組成物および組合せ
EP4649317A2 (en) * 2023-01-12 2025-11-19 Population Bio, Inc. Methods and compositions for screening and treating alzheimer's disease
CN116270603B (zh) * 2023-03-24 2024-08-06 黑龙江八一农垦大学 一种大豆苷元在制备用于缓解冷应激导致的肝损伤的药物中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009102324A (ja) 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
US20160213702A1 (en) 2015-01-26 2016-07-28 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
WO2016122889A1 (en) 2015-01-26 2016-08-04 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
WO2017035412A1 (en) 2015-08-25 2017-03-02 Kaleido Biosciences, Inc. Glycan compositions and uses thereof

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2027904A (en) 1933-02-16 1936-01-14 Int Suiker En Alcohol Cie Inte Method of polymerizing monosaccharides
US2436967A (en) 1942-04-01 1948-03-02 Corn Prod Refining Co Polymerization of sugars
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
US3876794A (en) 1972-12-20 1975-04-08 Pfizer Dietetic foods
US3973049A (en) 1974-03-14 1976-08-03 General Foods Corporation Method of mixing flavors and fixed composition comprising derivatized synthetic polysaccharides
JPS574922A (en) 1980-06-12 1982-01-11 Yakult Honsha Co Ltd Agent for lowering ammonia in blood
US4965354A (en) 1988-02-26 1990-10-23 Taito Company, Ltd. Process for producing a condensed polysaccharide
US5667593A (en) 1989-01-26 1997-09-16 Cultor Ltd. Modified polydextrose and process therefor
US5085883A (en) 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products
TW203106B (https=) 1991-07-18 1993-04-01 Textilma Ag
JPH06121693A (ja) 1992-08-25 1994-05-06 Akebono Brake Res & Dev Center Ltd 高重合度オリゴ糖の製造法
FR2697023B1 (fr) 1992-10-16 1994-12-30 Roquette Freres Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère .
EP0968232B1 (en) 1997-03-19 2004-02-25 Danisco USA Inc. Polymerization of mono-and disaccharides using low levels of mineral acids
US6475552B1 (en) 1997-03-19 2002-11-05 Danisco Finland Oy Polymerization of mono and disaccharides using low levels of polycarboxylic acids
CN1088714C (zh) 1997-03-19 2002-08-07 考尔特食品科学公司 采用少量多元羧酸使单糖和二糖类聚合制备可食用聚糖的方法
DE19860376A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha-1,4 Glucanketten enthaltende Polysaccharide sowie Verfahren zu ihrer Herstellung
JP2003514913A (ja) 1999-11-24 2003-04-22 マサチューセッツ インスティテュート オブ テクノロジー 多糖、天然生成物及びコンビナトリアル・ライブラリの合成に有用な保護基
US7608291B2 (en) 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
US8227448B2 (en) 2000-12-27 2012-07-24 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
DE10147100A1 (de) 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
ATE339512T1 (de) 2002-06-07 2006-10-15 Suedzucker Ag Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung
US20060014717A1 (en) 2002-06-28 2006-01-19 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
ATE506450T1 (de) 2002-07-23 2011-05-15 Biogenerix Ag Synthese von oligosacchariden, glykolipiden und glykoproteinen unter verwendung bakterieller glykosyltransferasen
CA2496990A1 (en) 2002-08-23 2004-03-04 E.I. Du Pont De Nemours And Company Utilization of starch products for biological production by fermentation
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
FI20021772A7 (fi) 2002-10-04 2004-04-05 Biotie Therapies Oyj Uudet hiilihydraattikoostumukset ja menetelmä niiden valmistamiseksi
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
EP1596843A2 (en) 2003-01-28 2005-11-23 Purdue Research Foundation Slowly digestible starch
CA2467695C (en) 2003-05-20 2010-03-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isomaltooligosaccharides from leuconostoc as neutraceuticals
KR100857500B1 (ko) 2003-06-30 2008-09-08 클라사도 인크. 신규한 갈락토올리고사카라이드 조성물 및 그 제조방법
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
DE102004058811A1 (de) 2004-12-07 2006-06-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Zuckeralkoholen
WO2007010084A2 (en) 2005-07-15 2007-01-25 Johannes Savolainen Immunostimulatory oligo- and polysaccharides and uses thereof
RU2395218C2 (ru) 2005-10-24 2010-07-27 Нестек С.А. Композиция пищевых волокон для профилактики или лечения заболеваний пищеварительной системы и композиция пищевых волокон, эффективная при лечении холеры
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US7915235B2 (en) 2006-03-20 2011-03-29 Brian Dieckgraefe High affinity ligands bind to clostridium difficile toxin A
EP2012807A4 (en) 2006-04-10 2009-07-08 Dikovskiy Aleksander Vladimiro PHARMACEUTICAL COMPOSITION FROM AN ENTEROSORBEN AND PREBIOTIKA, DOSAGE FORMS AND METHOD FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
EP1887017A1 (en) 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
FI20065593A7 (fi) 2006-09-26 2008-03-27 Valio Oy Menetelmä galakto-oligosakkarideja sisältävien tuotteiden valmistamiseksi ja niiden käyttö
US20130216693A1 (en) 2007-01-24 2013-08-22 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
ES2304223B2 (es) 2007-03-08 2009-05-01 Universidad De Sevilla Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion.
WO2008156354A1 (en) 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
AR077520A1 (es) 2007-12-21 2011-09-07 Nutricia Nv Uso de esfingomielina y carbohidratos no digeribles para mejorar la microbiota intestinal
PT2355670E (pt) 2008-12-10 2013-07-04 Fugeia Nv Produto alimentar contendo arabinoxilano e oligossacáridos
WO2010105207A1 (en) 2009-03-13 2010-09-16 The Regents Of The University Of California Prebiotic oligosaccharides
EP2427499A1 (en) 2009-05-07 2012-03-14 Tate&Lyle Ingredients France SAS Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
EP2248907A1 (en) 2009-05-08 2010-11-10 Rijksuniversiteit Groningen Gluco-oligosaccharides comprising (alpha 1-->4) and (alpha 1-->6) glycosidic bonds, use thereof, and methods for providing them
AU2009347008B2 (en) 2009-05-27 2013-08-15 Clasado Limited Method of preventing diarrhoea
CN102497868A (zh) 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
US8691792B2 (en) 2009-08-05 2014-04-08 Nestec Sa Methods and compositions for improving gastrointetinal health
EP2401925B1 (fr) 2010-06-29 2014-05-07 Rosebud AG Produit prebiotique et procede de fabrication
US20140187474A1 (en) 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
US9079171B2 (en) 2011-02-28 2015-07-14 Midori Usa, Inc. Polymeric acid catalysts and uses thereof
WO2013082562A1 (en) 2011-11-30 2013-06-06 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FR2987360B1 (fr) 2012-02-28 2014-03-28 Roquette Freres Maltodextrines hyperbranchees hypo-glycemiantes
EP2666788A1 (en) 2012-05-21 2013-11-27 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Glucan fibre
KR20150047583A (ko) 2012-08-24 2015-05-04 미도리 리뉴어블즈 인코퍼레이티드 중합체 촉매와 고체-지지된 촉매, 및 이러한 촉매를 사용하여 셀룰로오스 물질을 분해하는 방법
US20150202607A1 (en) 2012-08-24 2015-07-23 Midori Renewables, Inc. Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts
EP2888043A4 (en) 2012-08-24 2016-05-04 Midori Usa Inc POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTIONING LIGNIN-CONTAINING SUBSTANCES USING SUCH CATALYSTS
US9238845B2 (en) 2012-08-24 2016-01-19 Midori Usa, Inc. Methods of producing sugars from biomass feedstocks
EP2769726B1 (en) 2013-02-21 2018-10-31 Jennewein Biotechnologie GmbH Synthetic or recombinant fucosylated Oligosaccarides for use in the treatment of infections
JP2016512569A (ja) 2013-03-14 2016-04-28 ミドリ ユーエスエー，インコーポレイテッド 高分子イオン性塩触媒及びその製造方法
CA2906984A1 (en) 2013-03-15 2014-09-18 Cargill, Incorporated Carbohydrate compositions
EP3125905A4 (en) 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
CN107001528A (zh) 2014-07-09 2017-08-01 米德瑞（美国）有限公司 低聚糖组合物及其制备方法
SG11201704543XA (en) 2014-12-05 2017-07-28 Synlogic Inc Bacteria engineered to treat diseases associated with hyperammonemia
CA2975093A1 (en) 2015-01-26 2016-08-04 Midori Usa, Inc. Oligosaccharide compositions for use in nutritional compositions, and methods of producing thereof
HK1246600B (en) 2015-01-26 2020-04-09 Cadena Bio, Inc. Oligosaccharide compositions for use animal feed and methods of producing thereof
HK1246604A1 (zh) 2015-01-26 2018-09-14 Cadena Bio, Inc. 用作食品成分的寡糖组合物和其制造方法
FR3032709B1 (fr) 2015-02-16 2017-02-24 Roquette Freres Malto-oligo-saccharides riches en fibres et presentant une faible biosdisponibilite en glucose, leur procede de fabrication et leurs utilisations en nutrition humaine et animale
WO2016172658A2 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Microbiome regulators and related uses thereof
CA2983236A1 (en) * 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
WO2017083520A1 (en) 2015-11-13 2017-05-18 Cadena Bio, Inc. Animal therapeutic and feed compositions and methods of use
US20210137964A1 (en) * 2016-07-13 2021-05-13 Kaleido Biosciences, Inc. Glycan compositions and methods of use
CA3046207A1 (en) * 2016-12-06 2018-06-14 Kaleido Biosciences, Inc. Glycan polymers and related methods thereof
CA3118909A1 (en) 2018-11-08 2020-05-14 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009102324A (ja) 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
US20160213702A1 (en) 2015-01-26 2016-07-28 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
WO2016122889A1 (en) 2015-01-26 2016-08-04 Kaleido Biosciences, Inc. Glycan therapeutics and related methods thereof
WO2017035412A1 (en) 2015-08-25 2017-03-02 Kaleido Biosciences, Inc. Glycan compositions and uses thereof

Also Published As

Publication number Publication date
US20220233577A1 (en) 2022-07-28
EP3703705A2 (en) 2020-09-09
CN111315388A (zh) 2020-06-19
EP3703705B1 (en) 2024-05-15
US12090168B2 (en) 2024-09-17
WO2019090182A2 (en) 2019-05-09
JP2021502339A (ja) 2021-01-28
WO2019090182A3 (en) 2019-06-06

Similar Documents

Publication Publication Date Title
JP7576375B2 (ja) グリカン調製物及び高アンモニア血症のための使用方法
JP7675309B2 (ja) グリカン治療剤及びその関連方法
US11697692B2 (en) Methods of producing glycan polymers
JP2025142196A (ja) グリカンポリマーおよびその関連方法
AU2017200343B2 (en) Prebiotic formulations and methods of use
JP7822689B2 (ja) グリカン組成物および使用方法
EP3862006A1 (en) Glycan preparations for the treatment of infection
HK1166236B (en) Prebiotic formulations and methods of use

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211102

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211102

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20220708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230711

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231005

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240402

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240626

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241002

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241008

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241017

R150 Certificate of patent or registration of utility model

Ref document number: 7576375

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350